Immunological changes in liver disease. - Wikidata - wikimedia - TriplyDB

Immunological changes in liver disease.

Immunological changes in liver disease.

http://www.wikidata.org/entity/Q34983064

about

Impaired monocyte function in liver cirrhosis Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment.Development of Hodgkin's disease in the course of liver cirrhosis and impaired monocyte function.

P2860

Q34779314-CA10A59D-5188-4BB9-81C0-C63A93F61B2A Q37718004-0036D27D-7F0E-4383-9932-A6B6DFD3C937 Q38936801-5F2689F8-8678-4998-A12C-31B352F20468

P2860

Immunological changes in liver disease.

http://www.wikidata.org/entity/Q34983064

description

1977 nî lūn-bûn

@nan

1977 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1977 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1977年の論文

@ja

1977年論文

@yue

1977年論文

@zh-hant

1977年論文

@zh-hk

1977年論文

@zh-mo

1977年論文

@zh-tw

1977年论文

@wuu

name

Immunological changes in liver disease.

@ast

Immunological changes in liver disease.

@en

Immunological changes in liver disease.

@nl

type

label

Immunological changes in liver disease.

@ast

Immunological changes in liver disease.

@en

Immunological changes in liver disease.

@nl

prefLabel

Immunological changes in liver disease.

@ast

Immunological changes in liver disease.

@en

Immunological changes in liver disease.

@nl

P1433

Q34983064-55C86880-5BD7-4BC6-94C3-1538F3A26E0C

P1476

Q34983064-476BDFF0-6710-4BF8-9B54-B9AF7247F39C

P2093

Q34983064-7A7D9920-B6E4-4CCD-AF7E-A46CA0C0F483

P2860

Q34983064-0AB24B78-3D3E-4E9C-9BD3-6CE2C8A1F537

Q34983064-238A3BFE-B330-4CBA-9BE5-E45D477CB8A6

Q34983064-34AD160C-4DC6-44B0-B401-EFFF0CA7D89D

Q34983064-426E1ACA-8819-48B4-8EAB-64FE7FF30474

Q34983064-48F23ABF-50C3-4E1A-BDA6-CDA63E3C10D8

Q34983064-6D493BB6-B33B-4556-98EC-B6364C8D7A17

Q34983064-83C4598F-28F7-432B-92BA-340B6AF69EE9

Q34983064-93625E03-C10E-4B57-8B44-994540393877

Q34983064-97CB6E1D-4F47-4F0A-BCE4-7568E4227335

Q34983064-A0DC2DB5-A92C-4D12-85FF-E295F9E230E3

P304

Q34983064-CED91361-6CA9-4D74-AF3E-AF1FB8DB8048

P31

Q34983064-8279ECA2-5484-4AA5-9766-1C7FB004867A

Q34983064-daf618aa-42b4-40b5-8693-be193592703f

P407

Q34983064-A7D1D07A-9395-446D-9106-2839FEAA2965

P433

Q34983064-6151094A-D7DF-4DC5-9802-AD291226306E

P478

Q34983064-1024D165-2FBC-4F49-928C-B175A07F9C04

P577

Q34983064-2BC247DD-9EA2-4427-87D1-B102BAC55983

P698

Q34983064-CBCA3952-1C63-4AED-AB9B-B7143A317640

P921

Q34983064-748987C7-B268-483C-88E2-A16345976DDF

P932

Q34983064-C47D8332-87A8-4906-ADBC-2EDB8F51FDBB

P1433

Journal of the Royal Society of Medicine

P1476

Immunological changes in liver disease.

@en

P2093

Sherlock S

http://www.w3.org/2001/XMLSchema#string

P2860

Association of autoimmune active chronic hepatitis with HL-A1,8.

Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

Paraproteins with antibody activity in acute viral hepatitis and chronic autoimmune liver diseases.

Two immunologic reactions in the pathogenesis of hepatitis?

Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Studies on the specificity of smooth-muscle antibodies.

A unified concept of autoimmune hepatitis.

High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.

Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

Studies on hepatic uptake of antigen. I. Comparison of inferior vena cava and portal vein routes of immunization.

P304

851-855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

1977-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

341172

http://www.w3.org/2001/XMLSchema#string

P921

P932

1543549

http://www.w3.org/2001/XMLSchema#string